Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Previously we showed that biodegradable nanoparticles containing poly-IC or CpG oligodeoxynucleotide (ODN) together with ovalbumin (OVA) were efficient at inducing MHC-restricted presentation of OVA peptides in dendritic cells. The CTL-inducing activities of the nanoparticles were examined in the present study. Nanoparticles containing poly-IC or CpG ODN together with OVA were prepared using biodegradable polymer poly(D,L-lactic acid-co-glycolic acid),and then were opsonized with mouse IgG. The nanoparticles were injected into the tail vein of mice, and 7 days later the OVA-specific CTL activities were measured using an in vivo CTL assay. Immunization of mice with the nanoparticles containing poly-IC or CpG ODN together with OVA elicited potent OVA-specific CTL activity compared to those containing OVA only. In accordance with these results, nanoparticles containing poly-IC or CpG ODN together with OVA exerted potent antitumor activity in mice that were subcutaneously implanted with EG7.OVA tumor cells. These results show that encapsulation of poly-IC or CpG ODN together with antigen in biodegradable nanoparticles is an effective approach for the induction of potent antigen-specific CTL responses in vivo.
Abstract
Previously we showed that biodegradable nanoparticles containing poly-IC or CpG oligodeoxynucleotide (ODN) together with ovalbumin (OVA) were efficient at inducing MHC-restricted presentation of OVA peptides in dendritic cells. The CTL-inducing activities of the nanoparticles were examined in the present study. Nanoparticles containing poly-IC or CpG ODN together with OVA were prepared using biodegradable polymer poly(D,L-lactic acid-co-glycolic acid),and then were opsonized with mouse IgG. The nanoparticles were injected into the tail vein of mice, and 7 days later the OVA-specific CTL activities were measured using an in vivo CTL assay. Immunization of mice with the nanoparticles containing poly-IC or CpG ODN together with OVA elicited potent OVA-specific CTL activity compared to those containing OVA only. In accordance with these results, nanoparticles containing poly-IC or CpG ODN together with OVA exerted potent antitumor activity in mice that were subcutaneously implanted with EG7.OVA tumor cells. These results show that encapsulation of poly-IC or CpG ODN together with antigen in biodegradable nanoparticles is an effective approach for the induction of potent antigen-specific CTL responses in vivo.
참고문헌 (20)
- Van Der Bruggen. P, "Tumor-specific shared antigenic peptides recognized by human T cells", Immunol. Rev, 188, pp.51~64 (2002)
- Huang, A. Y., "Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens", Science, 264, pp.961~965 (1994)
- Harding, C. V., "Phagocytic processing of antigens for presentation by MHC molecules", Trends Cell Biol, 5, pp.105~109 (1995)
- Sigal, L. J., "Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen", Nature, 398, pp.77~80 (1999)
- Heath, W. R, "Cross-presentation, dendritic cells, tolerance and immunity", Annu. Rev. Immunol, 19, pp.47~64 (2001)
- Carbone, F. R., "Cross-presentation: a general mechanism for CTL immunity and tolerance", Immunol. Today, 19, pp.368~373 (1998)
- Shen, H., "Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles", Immunology, 117, pp.78~88 (2006)
- Turmunkh Gerelchuluun, "Dendritic Cells Process Antigens Encapsulated in a Biodegradable Polymer, Poly(D,L-lactide-co-glycolide), via an Alternate Class I MHC Processing Pathway", Archives of Pharmacal Research, 30(11), pp.1440~1446 (2007), 대한약학회
- Young-Ran Lee, "Biodegradable Nanoparticles Containing TLR3 or TLR9 Agonists Together with Antigen Enhance MHC-restricted Presentation of the Antigen", Archives of Pharmacal Research, 33(11), pp.1859~1866 (2010), 대한약학회
- Schliehe, C., "CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphereencapsulated antigen in vivo", J. Immunol, 187, pp.2112~2121 (2011)
- Newman, K. D., "Delivery of MUC1 mucin peptide by Poly (d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses", J. Pharm. Sci, 87, pp.1421~1427 (1998)
- Venkataprasad, N., "Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers", Vaccine, 17, pp.1814~1819 (1999)
- Lee, Y. R., "Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells", Blood, 105, pp.3951~3955 (2005)
- Panyam, J., "Biodegradable nanoparticles for drug and gene delivery to cells and tissue", Adv. Drug Deliv. Rev, 55, pp.329~347 (2003)
- Moore, M. W., "Introduction of soluble protein into the class I pathway of antigen processing and presentation", Cell, 54, pp.777~785 (1988)
- Panyam, J., "Biodegradable nanoparticles for drug and gene delivery to cells and tissue", Adv. Drug Deliv. Rev, 55, pp.329~347 (2003)
- Pfeifer, J. D., "Phagocytic processing of bacterial antigens for class I MHC presentation to T cells", Nature, 361, pp.359~362 (1993)
- Elamanchili, P., "Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells", Vaccine, 22, pp.2406~2412 (2004)
- Lee, Y. H., "Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells", Int. Immunopharmacol, 11, pp.985~991 (2011)
- 이영란, "Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen", Immune Network, 11(3), pp.163~168 (2011), 대한면역학회